First Round Capital

First Round Capital, established in 2004, is a San Francisco-based venture capital firm specializing in seed-stage investments. It focuses on building a robust community of technology entrepreneurs and companies, providing custom software solutions, in-person experiences, and unique services to help early-stage companies grow. First Round Capital has invested in notable startups like Uber, Square, and Warby Parker, and has adopted the Diversity Term Sheet Rider to promote diversity in its portfolio. The firm invests nationally, with additional offices in San Francisco and New York, typically providing around $500,000 in the initial investment. It actively supports its portfolio companies and has facilitated a VC-sponsored exchange fund for qualified entrepreneurs. To date, members of the First Round Capital community have raised over $2.5 billion in follow-on capital.

Meka Asonye

Partner

Brett Berson

Partner

Jeff Donnon

CFO

Amy Fu

Vice President of Investments

Todd Jackson

Partner

Josh Kopelman

Founder and Partner

Whitnie Narcisse

Operating Partner

James Wu

Infrastructure and AI / ML Investor

Past deals in Health Diagnostics

Collate

Seed Round in 2025
Collate creates and streamlines documentation for drug development, medical device, and diagnostic companies from concept to market using artificial intelligence. They produce accurate documentation for the life sciences industry, which speeds up innovations that can save lives.

Candid Health

Series B in 2024
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Pomelo Care

Series B in 2024
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

Boulder Care

Venture Round in 2024
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Ossium Health

Series C in 2023
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Pomelo Care

Series A in 2023
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

Koala Health

Series A in 2022
Koala Health is a Boston-based company founded in 2021 that specializes in providing medications and health products for pets. The company simplifies pet care by verifying and fetching prescriptions from veterinarians, sorting and packaging medications by date and time, and offering free delivery and refills. By focusing on vet-approved medications and supplements, Koala Health aims to enhance the quality of life for pets and support pet owners in managing their pets' health needs effectively.

Boulder Care

Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Source

Seed Round in 2022
Source is a digital healthcare delivery platform founded in 2021 and headquartered in New York, United States. The company provides an operating system that enables care delivery organizations to connect with patients, coordinate care, schedule visits, and capture essential data. By facilitating collaboration among product leaders, engineers, and clinicians, Source aims to enhance healthcare experiences with a patient-centered approach. Its enterprise system is designed to support healthcare providers of all sizes in improving their virtual care capabilities.

Candid Health

Series A in 2022
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

House Rx

Series A in 2022
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Rupa Health

Series A in 2022
Rupa Health, established in 2018 and headquartered in San Francisco, operates an online platform that streamlines lab testing for healthcare providers. It facilitates ordering tests from various labs, tracks results, and delivers reports directly to patients' homes. The platform integrates with electronic health records, supports both in-person and telehealth patients, and offers custom lab bundles, flexible payment options, and robust support for practitioners and patients.

Vital

Series A in 2021
Vital is a health insurance company that offers innovative financial solutions, including medical credit lines and loans, to help patients manage their healthcare expenses. Additionally, Vital employs AI-powered technology to enhance patient experience, providing real-time information and support throughout their healthcare journey, from emergency room visits to post-discharge care.

Pomelo Care

Seed Round in 2021
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

House Rx

Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Rupa Health

Seed Round in 2021
Rupa Health, established in 2018 and headquartered in San Francisco, operates an online platform that streamlines lab testing for healthcare providers. It facilitates ordering tests from various labs, tracks results, and delivers reports directly to patients' homes. The platform integrates with electronic health records, supports both in-person and telehealth patients, and offers custom lab bundles, flexible payment options, and robust support for practitioners and patients.

Ossium Health

Series B in 2021
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Sitka

Series A in 2021
Sitka, Inc. operates an online communication platform that connects patients with healthcare providers across various specialties, including endocrinology, neurology, orthopedics, pulmonology, and rheumatology. Founded in 2018 by experts in healthcare, technology, and policy, the company aims to transform specialty care in the United States by enhancing the capabilities of primary care providers and facilitating patient involvement in their care. The platform allows for personalized consultations, such as interpreting MRI results with board-certified doctors, thereby improving patients' understanding of their health conditions and enabling better decision-making. Headquartered in Carmel, California, Sitka is supported by a range of investors and is dedicated to fostering effective and trusted care delivery for all patients through its innovative solutions.

DNAnexus

Series G in 2020
DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

Boulder Care

Series A in 2020
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Vital

Seed Round in 2019
Vital is a health insurance company that offers innovative financial solutions, including medical credit lines and loans, to help patients manage their healthcare expenses. Additionally, Vital employs AI-powered technology to enhance patient experience, providing real-time information and support throughout their healthcare journey, from emergency room visits to post-discharge care.

Boulder Care

Venture Round in 2018
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Keeps

Series A in 2018
2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Thirty Madison

Series A in 2018
Thirty Madison, Inc. is a digital health company based in Astoria, New York, that focuses on providing specialized healthcare solutions for patients with chronic conditions. Founded in 2016, the company operates several condition-specific brands, including Keeps, which offers a subscription-based service for men’s hair loss prevention; Cove, which provides online consultations and prescriptions for migraine treatment; Picnic, targeting allergies; Facet for skin conditions; and NURX for sexual health. Each brand is designed to address the unique needs of its community, offering personalized treatments and support. Thirty Madison emphasizes a human-centered approach, empowering individuals with accessible and effective healthcare solutions tailored to their ongoing conditions.

Cricket Health

Series A in 2018
Cricket Health Inc. is a specialty kidney care provider focused on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, California, the company employs a technology-enabled, evidence-based approach to manage kidney diseases. Cricket Health aims to enhance patient outcomes and value for healthcare partners by providing multidisciplinary care both in-person and virtually. Their services are designed to keep patients healthy, reduce hospitalizations, accelerate access to transplants, and promote home dialysis adoption. By identifying at-risk patients and acting early, Cricket Health supports personalized treatment options that include transplant support, home dialysis, conservative care, and in-center dialysis.

Gregor Diagnostics

Seed Round in 2018
Gregor Diagnostics Inc. is a molecular diagnostics company based in Madison, Wisconsin, founded in 2016. The company focuses on developing innovative screening tests for prostate cancer, utilizing seminal fluid as a sample source. Its technology aims to detect prostate cancer at early stages and differentiate between indolent and aggressive forms of the disease. This capability enables physicians to minimize overdiagnosis and overtreatment of less aggressive cancer while enhancing the detection and management of more aggressive cases. Gregor Diagnostics' approach represents a significant advancement in the field of prostate cancer diagnostics.

Studio

Series A in 2018
Studio operates a connected fitness platform that streams live and on-demand classes to users in their homes through a sleek, responsive display. The system personalizes content in real-time by utilizing user feedback and biometric data, allowing access to a diverse range of classes, including cardio, strength training, and yoga. Founded in 2016 and headquartered in New York, Studio aims to enhance the fitness experience by combining technology with user engagement to promote a healthier lifestyle.

Keeps

Seed Round in 2017
2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Thirty Madison

Seed Round in 2017
Thirty Madison, Inc. is a digital health company based in Astoria, New York, that focuses on providing specialized healthcare solutions for patients with chronic conditions. Founded in 2016, the company operates several condition-specific brands, including Keeps, which offers a subscription-based service for men’s hair loss prevention; Cove, which provides online consultations and prescriptions for migraine treatment; Picnic, targeting allergies; Facet for skin conditions; and NURX for sexual health. Each brand is designed to address the unique needs of its community, offering personalized treatments and support. Thirty Madison emphasizes a human-centered approach, empowering individuals with accessible and effective healthcare solutions tailored to their ongoing conditions.

Studio

Seed Round in 2016
Studio operates a connected fitness platform that streams live and on-demand classes to users in their homes through a sleek, responsive display. The system personalizes content in real-time by utilizing user feedback and biometric data, allowing access to a diverse range of classes, including cardio, strength training, and yoga. Founded in 2016 and headquartered in New York, Studio aims to enhance the fitness experience by combining technology with user engagement to promote a healthier lifestyle.

Ossium Health

Seed Round in 2016
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Forward

Seed Round in 2016
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

SchoolCare

Debt Financing in 2016
SchoolCare is a digital health platform dedicated to enhancing pediatric healthcare in K-12 public schools. By providing free health technology, it assists school nurses in delivering effective care and ensuring student safety. The platform captures essential health information, including student medical charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. This connectivity allows for timely alerts about health events and supports the efficient operation of public school health programs. By addressing gaps in traditional care coordination, SchoolCare aims to improve health outcomes for children, ensuring that they receive consistent and comprehensive care throughout their school experience.

Cricket Health

Seed Round in 2016
Cricket Health Inc. is a specialty kidney care provider focused on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, California, the company employs a technology-enabled, evidence-based approach to manage kidney diseases. Cricket Health aims to enhance patient outcomes and value for healthcare partners by providing multidisciplinary care both in-person and virtually. Their services are designed to keep patients healthy, reduce hospitalizations, accelerate access to transplants, and promote home dialysis adoption. By identifying at-risk patients and acting early, Cricket Health supports personalized treatment options that include transplant support, home dialysis, conservative care, and in-center dialysis.

PatientPing

Series A in 2015
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Sano

Seed Round in 2015
Sano is focused on developing a small, wearable transdermal biosensor patch that continuously captures and transmits blood chemistry data. This innovative technology measures interstitial fluid in the skin's outer layer, allowing for continuous glucose monitoring. By providing real-time data, Sano's solution enables individuals to make more informed decisions regarding their diet and exercise habits. The collected data can be accessed through a third-party development and analytical platform, referred to as the API for the bloodstream, enhancing users' ability to optimize their health behaviors.

Cricket Health

Convertible Note in 2015
Cricket Health Inc. is a specialty kidney care provider focused on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, California, the company employs a technology-enabled, evidence-based approach to manage kidney diseases. Cricket Health aims to enhance patient outcomes and value for healthcare partners by providing multidisciplinary care both in-person and virtually. Their services are designed to keep patients healthy, reduce hospitalizations, accelerate access to transplants, and promote home dialysis adoption. By identifying at-risk patients and acting early, Cricket Health supports personalized treatment options that include transplant support, home dialysis, conservative care, and in-center dialysis.

NeuroVigil

Series B in 2015
NeuroVigil, Inc. is a neurodiagnostics company specializing in non-invasive brain monitoring technologies. Its flagship product, iBrain, is a wireless portable platform designed to automate the reading of brain wave data. This device is utilized across various sectors, including pharmaceuticals, government, and academia, to monitor a range of neuropathologies such as Alzheimer's, autism, depression, and PTSD. iBrain enables the analysis of high-resolution EEG data, facilitating research in conditions like ALS without the constraints of traditional clinical environments. The technology supports clinical trials and sleep studies, helping to assess drug efficacy and monitor brain response to treatments. Founded in 2007 and headquartered in La Jolla, California, NeuroVigil continues to advance its capabilities in neurotechnology and machine learning to enhance the understanding and management of neurological disorders.

SchoolCare

Seed Round in 2014
SchoolCare is a digital health platform dedicated to enhancing pediatric healthcare in K-12 public schools. By providing free health technology, it assists school nurses in delivering effective care and ensuring student safety. The platform captures essential health information, including student medical charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. This connectivity allows for timely alerts about health events and supports the efficient operation of public school health programs. By addressing gaps in traditional care coordination, SchoolCare aims to improve health outcomes for children, ensuring that they receive consistent and comprehensive care throughout their school experience.

Flatiron Health

Series B in 2014
Flatiron Health, Inc. is a healthcare technology company dedicated to enhancing cancer research and patient care through advanced data integration and analytics. The firm develops OncologyCloud, a comprehensive platform that consolidates disparate healthcare information systems to provide insights into patient populations. This platform enables cancer care providers and life sciences companies to analyze treatment patterns, monitor adherence to clinical guidelines, and facilitate real-time patient matching to clinical trials. Additionally, Flatiron offers OncoCloud, a software solution for community oncology practices, and tools like Flatiron Assist and OncoEMR, which support clinical decision-making and compliance with oncology care models. Established in 2012 and headquartered in New York, Flatiron Health collaborates with over 280 community cancer practices, prominent academic research centers, and leading oncology companies, positioning itself as a key player in the oncology data landscape. The company operates as a subsidiary of Roche Holding AG.

DNAnexus

Series C in 2014
DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

New Ocean Health Solutions

Series A in 2013
New Ocean Health Solutions is a software design and development company that specializes in creating an enterprise health management platform. This platform includes valuable health and well-being programs aimed at enhancing overall wellness. One of its key offerings is Bridge, an integration and optimization platform that connects various components of the healthcare system. The company also provides personalized, rewards-based programs for members and employees, helping them achieve their health goals, ranging from improved well-being to chronic condition management. Founded in 2013 and headquartered in Conshohocken, Pennsylvania, with additional operations in Greenville, South Carolina, New Ocean Health Solutions was previously known as Care Cam Innovations, LLC.

Flatiron Health

Series A in 2013
Flatiron Health, Inc. is a healthcare technology company dedicated to enhancing cancer research and patient care through advanced data integration and analytics. The firm develops OncologyCloud, a comprehensive platform that consolidates disparate healthcare information systems to provide insights into patient populations. This platform enables cancer care providers and life sciences companies to analyze treatment patterns, monitor adherence to clinical guidelines, and facilitate real-time patient matching to clinical trials. Additionally, Flatiron offers OncoCloud, a software solution for community oncology practices, and tools like Flatiron Assist and OncoEMR, which support clinical decision-making and compliance with oncology care models. Established in 2012 and headquartered in New York, Flatiron Health collaborates with over 280 community cancer practices, prominent academic research centers, and leading oncology companies, positioning itself as a key player in the oncology data landscape. The company operates as a subsidiary of Roche Holding AG.

Sano

Seed Round in 2013
Sano is focused on developing a small, wearable transdermal biosensor patch that continuously captures and transmits blood chemistry data. This innovative technology measures interstitial fluid in the skin's outer layer, allowing for continuous glucose monitoring. By providing real-time data, Sano's solution enables individuals to make more informed decisions regarding their diet and exercise habits. The collected data can be accessed through a third-party development and analytical platform, referred to as the API for the bloodstream, enhancing users' ability to optimize their health behaviors.

Mango Health

Seed Round in 2012
Mango Health, Inc. specializes in developing mobile healthcare applications aimed at enhancing patient engagement, particularly for individuals with chronic conditions. The company's platform offers features such as medication information, refill reminders, and peer comparisons, facilitating better management of complex health issues. Mango Health's services are accessible through both mobile and web-based applications, reflecting its commitment to user-friendly solutions. Since its incorporation in 2011, the company has partnered with payers, pharmacy benefits managers, and pharmaceutical manufacturers to improve health outcomes and reduce costs. The Mango Health app has garnered a 4.5-star user rating and has received recognition from major media outlets, underscoring its impact in the healthcare sector. As of October 2019, Mango Health operates as a subsidiary of TrialCard Incorporated and is based in San Francisco, California.

Mango Health

Seed Round in 2012
Mango Health, Inc. specializes in developing mobile healthcare applications aimed at enhancing patient engagement, particularly for individuals with chronic conditions. The company's platform offers features such as medication information, refill reminders, and peer comparisons, facilitating better management of complex health issues. Mango Health's services are accessible through both mobile and web-based applications, reflecting its commitment to user-friendly solutions. Since its incorporation in 2011, the company has partnered with payers, pharmacy benefits managers, and pharmaceutical manufacturers to improve health outcomes and reduce costs. The Mango Health app has garnered a 4.5-star user rating and has received recognition from major media outlets, underscoring its impact in the healthcare sector. As of October 2019, Mango Health operates as a subsidiary of TrialCard Incorporated and is based in San Francisco, California.

DNAnexus

Series B in 2011
DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

SchoolCare

Seed Round in 2011
SchoolCare is a digital health platform dedicated to enhancing pediatric healthcare in K-12 public schools. By providing free health technology, it assists school nurses in delivering effective care and ensuring student safety. The platform captures essential health information, including student medical charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. This connectivity allows for timely alerts about health events and supports the efficient operation of public school health programs. By addressing gaps in traditional care coordination, SchoolCare aims to improve health outcomes for children, ensuring that they receive consistent and comprehensive care throughout their school experience.

Medico.com

Seed Round in 2011
Medico.com is a global health-focused internet company that operates an online health portal designed to provide users with access to reliable health information. Initially targeting users in Spain, the platform aims to expand into other Hispanic markets, including the United States, and plans to include additional languages and markets such as India. Medico.com features a comprehensive library of over 4,000 articles covering various diseases and conditions, complemented by continuously updated health news. The portal also includes community features and a question-and-answer platform organized around specific health topics, allowing users to share experiences, exchange information, and actively participate in managing their health. The service is offered free of charge to users.

DNAnexus

Series A in 2009
DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.